United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded May 11, 2026 · Filed May 12, 2026

On May 11, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$573.03 for US$5.73M under a trading plan, leaving 18,876 shares. Filed May 12, 2026 (Form 4).

Sold
10,000 shares
Price
US$573.03 average (US$569.46 to US$580.45)
Value
US$5.73M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 11, 2026Common StockOption exercise10,000US$135.4228,876Direct
May 11, 2026Common StockSale1,289US$569.4627,587Direct
May 11, 2026Common StockSale2,059US$570.1725,528Direct
May 11, 2026Common StockSale1,496US$571.4224,032Direct
May 11, 2026Common StockSale1,356US$572.3222,676Direct
May 11, 2026Common StockSale480US$573.2222,196Direct
May 11, 2026Common StockSale661US$574.5721,535Direct
May 11, 2026Common StockSale530US$575.2621,005Direct
May 11, 2026Common StockSale89US$576.6820,916Direct
May 11, 2026Common StockSale893US$577.5920,023Direct
May 11, 2026Common StockSale476US$578.4219,547Direct
May 11, 2026Common StockSale591US$579.8018,956Direct
May 11, 2026Common StockSale80US$580.4518,876Direct

Source

View original at SEC

Related